Rahoto kan sakamakon kudi na kamfanin Elite Pharmaceuticals, Inc., Elite Pharmaceuticals, Inc. shekara-shekara na samun kudin shiga ga shekara ta 2024. Yaushe Elite Pharmaceuticals, Inc. buga rahotanni na kudi?
Elite Pharmaceuticals, Inc. jimlar kudaden shiga, ribar shiga gida da kuma sauye-sauye na canje-canje a US dollar a yau
Ynamarfin Elite Pharmaceuticals, Inc. kudaden shiga da aka samu ta hanyar -1 651 051 $ idan aka kwatanta da rahoton da ya gabata. Elite Pharmaceuticals, Inc. kudin shiga yanzu shine -482 623 $. Thearfin kuɗin shiga na Elite Pharmaceuticals, Inc. ya canza ta -2 494 756 $ a cikin 'yan shekarun nan. Shafin rahoton hada-hadar kudade a shafin yanar gizonmu yana nuna bayanan ta hanyar kwanakin da 31/03/2018 to 31/03/2021. Rahoton kuɗi a kan taswirar Elite Pharmaceuticals, Inc. yana ba ku damar bayyananniyar kuzarin kadarar kadara. Elite Pharmaceuticals, Inc. an nuna kudin shiga a shuɗi akan shuɗin zane.
Rahoton Rahoton
Jimlar kudade
An kiyasta yawan kudaden shiga ta hanyar ninka yawan kayan da aka sayar da farashin kaya.
kuma
Canji (%)
Daidaita rahoton da aka kai a shekara ta wannan shekara tare da rahoto na shekara ta bara.
Ribar kuɗi
Ribar kuɗi shine asusun kuɗi na ƙwarewar ya rage yawan kuɗin da aka sayar, farashi da haraji don lokacin yin rahoton.
kuma
Canji (%)
Daidaita rahoton da aka kai a shekara ta wannan shekara tare da rahoto na shekara ta bara.
31/03/2021
4 395 531 $
+227.1 % ↑
-482 623 $
-
31/12/2020
6 046 582 $
+19.61 % ↑
2 012 133 $
-
30/09/2020
7 399 892 $
+59.65 % ↑
2 481 562 $
-
30/06/2020
7 538 744 $
+124.42 % ↑
1 077 349 $
+285.18 % ↑
31/12/2019
5 055 113 $
-
-1 860 680 $
-
30/09/2019
4 634 987 $
-
-1 595 741 $
-
30/06/2019
3 359 240 $
-
279 702 $
-
31/03/2019
1 343 795 $
-
-2 663 705 $
-
31/12/2018
2 693 966 $
-
-2 344 318 $
-
30/09/2018
1 363 049 $
-
-2 583 532 $
-
30/06/2018
2 167 698 $
-
-1 687 766 $
-
31/03/2018
1 596 906 $
-
-2 829 414 $
-
Nuna:
To
Rahoton kudi Elite Pharmaceuticals, Inc., tsarawa
Zamanin sabbin bayanan kudi na Elite Pharmaceuticals, Inc.: 31/03/2018, 31/12/2020, 31/03/2021. Kwanan wata da bayanan bayanan kuɗi an kafa su ne ta hanyar dokokin ƙasar da kamfanin yake gudanar da ayyukanta. Sabuwar kwanan rahoton rahoton kudi na Elite Pharmaceuticals, Inc. shine 31/03/2021. Babban riba Elite Pharmaceuticals, Inc. shine ribar da kamfani ke karɓa bayan da ya rage kudin da ake samarwa da sayar da kayansa da / ko kudin da zai samar da ayyukansa. Babban riba Elite Pharmaceuticals, Inc. ne 1 865 941 $
Dates na kudi rahotanni Elite Pharmaceuticals, Inc.
Ribar kuɗi Elite Pharmaceuticals, Inc. shine asusun kuɗi na ƙwarewar ya rage yawan kuɗin da aka sayar, farashi da haraji don lokacin yin rahoton. Ribar kuɗi Elite Pharmaceuticals, Inc. ne -482 623 $
31/03/2021
31/12/2020
30/09/2020
30/06/2020
31/12/2019
30/09/2019
30/06/2019
31/03/2019
31/12/2018
30/09/2018
30/06/2018
31/03/2018
Babban riba
Babban riba shine ribar da kamfani ke karɓa bayan da ya rage kudin da ake samarwa da sayar da kayansa da / ko kudin da zai samar da ayyukansa.
1 865 941 $
3 403 407 $
3 621 396 $
2 976 394 $
2 891 737 $
1 328 731 $
1 298 954 $
532 903 $
922 830 $
820 498 $
591 299 $
1 135 613 $
Farashin farashi
Kudin shi ne yawan kuɗin da aka samar da rarraba kayayyaki da ayyuka na kamfanin.
2 529 590 $
2 643 175 $
3 778 496 $
4 562 350 $
2 163 376 $
3 306 256 $
2 060 286 $
810 892 $
1 771 136 $
542 551 $
1 576 399 $
461 293 $
Jimlar kudade
An kiyasta yawan kudaden shiga ta hanyar ninka yawan kayan da aka sayar da farashin kaya.
4 395 531 $
6 046 582 $
7 399 892 $
7 538 744 $
5 055 113 $
4 634 987 $
3 359 240 $
1 343 795 $
2 693 966 $
1 363 049 $
2 167 698 $
1 596 906 $
Hanyoyin shiga
Hanyoyin sarrafa kuɗi sun karu daga asusun kasuwancin kamfanin. Alal misali, mai sayar da kaya yana haifar da samun kudin shiga ta hanyar sayar da kayayyaki, kuma likita ya karbi kuɗi daga sabis na kiwon lafiya wanda ya bayar.
-
-
-
-
5 055 113 $
4 634 987 $
3 359 240 $
1 343 795 $
2 693 966 $
1 363 049 $
2 167 698 $
1 596 906 $
Haɗin aiki
Sakamakon aiki yana da ma'auni na lissafin kudi wanda ke daidaita yawan ribar da aka samu daga ayyukan kasuwanci, bayan da ya rage kudaden aiki, kamar albashi, haɓakawa da kuma kaya na kaya da aka sayar.
-1 067 503 $
1 001 169 $
1 340 257 $
830 600 $
691 195 $
-454 532 $
-1 147 705 $
-2 010 204 $
-2 637 130 $
-2 652 972 $
-1 858 394 $
-2 621 176 $
Ribar kuɗi
Ribar kuɗi shine asusun kuɗi na ƙwarewar ya rage yawan kuɗin da aka sayar, farashi da haraji don lokacin yin rahoton.
-482 623 $
2 012 133 $
2 481 562 $
1 077 349 $
-1 860 680 $
-1 595 741 $
279 702 $
-2 663 705 $
-2 344 318 $
-2 583 532 $
-1 687 766 $
-2 829 414 $
R & D kudi
Binciken bincike da ci gaba - kudaden bincike don inganta samfurori da hanyoyin da ake samuwa ko kuma samar da sababbin samfurori da hanyoyin.
1 775 255 $
1 245 669 $
1 147 739 $
943 879 $
986 832 $
637 489 $
1 408 036 $
1 363 628 $
2 454 098 $
2 455 466 $
1 326 628 $
2 677 183 $
Ayyukan sarrafawa
Kayan aiki shine kudaden da kasuwancin ke haifarwa saboda sakamakon ayyukan kasuwanci na yau da kullum.
5 463 034 $
5 045 413 $
6 059 635 $
6 708 144 $
4 363 918 $
5 089 519 $
4 506 945 $
3 353 999 $
5 331 096 $
4 016 021 $
4 026 092 $
4 218 082 $
Abubuwan da ke yanzu
Abubuwan da ake amfani da su a yanzu shine takarda na ma'auni wanda ya wakilta dukiyar dukiyar da za'a iya juyo cikin kuɗi a cikin shekara guda.
12 194 667 $
14 538 170 $
13 275 091 $
13 251 094 $
9 042 300 $
8 116 400 $
8 531 974 $
8 856 542 $
9 431 204 $
10 377 783 $
11 457 527 $
13 702 401 $
Total dukiya
Jimlar dukiyar kuɗi ce ta kuɗin kuɗin kuɗin kuɗin kuɗin kungiyar, bashin bashi, da dukiya na kayan aiki.
26 189 492 $
28 665 237 $
27 605 918 $
27 821 733 $
24 086 510 $
23 533 467 $
24 284 953 $
24 401 934 $
26 377 364 $
27 321 101 $
28 495 252 $
30 882 608 $
Kudi na yanzu
Kasuwanci na yanzu shine kudaden kuɗin da kamfanin ya gudanar a ranar rahoton.
3 192 768 $
5 412 785 $
4 365 667 $
2 787 640 $
1 870 080 $
2 256 388 $
2 576 948 $
2 277 643 $
3 680 559 $
4 705 189 $
5 644 053 $
7 179 237 $
Yanzu bashi
Dalili na yanzu shine ɓangare na bashin da za a biya a wannan shekara (watannin 12) kuma an nuna shi a matsayin wani alhaki na yanzu da kuma ɓangare na babban kamfanonin aiki.
-
-
-
-
7 746 372 $
7 168 853 $
7 611 460 $
6 906 132 $
6 940 409 $
5 364 427 $
4 670 973 $
5 114 704 $
Jimlar kuɗi
Jimlar kuɗin kuɗi ne adadin duk kuɗin da kamfanin yake da shi a cikin asusunsa, ciki har da ƙananan kuɗi da kudade da aka gudanar a banki.
-
-
-
-
-
-
-
-
-
-
-
-
Jimlar bashi
Jimlar bashi shine haɗuwa da gajeren lokaci da dogon lokaci. Lokaci bashi ne waɗanda dole ne a biya a cikin shekara guda. Lokaci na dogon lokaci ya hada da dukan wajibai waɗanda dole ne a biya su bayan shekara guda.
-
-
-
-
15 006 628 $
12 687 807 $
12 242 661 $
13 005 838 $
12 737 998 $
11 647 513 $
11 502 764 $
12 407 096 $
Yanayin bashi
Jimlar bashi ga duk dukiya shi ne haɗin kudi wanda ya nuna yawan yawan dukiyar da kamfanin ke wakilta a matsayin bashi.
-
-
-
-
62.30 %
53.91 %
50.41 %
53.30 %
48.29 %
42.63 %
40.37 %
40.18 %
Hakki
Adalci shine adadin dukan dukiya na mai shi bayan da ya cire duk wata albashi daga dukiyar kuɗi.
16 151 929 $
16 630 632 $
14 616 848 $
-2 115 269 $
-4 824 078 $
-3 058 300 $
-1 861 668 $
-2 507 864 $
-264 594 $
1 769 628 $
3 088 528 $
4 571 552 $
Cash flow
Cash flow is bashin tsabar kuɗi da tsabar kuɗin da ake ciki a cikin kungiyar.
-
-
-
-
-312 159 $
-463 798 $
188 273 $
-2 135 998 $
-1 268 037 $
-1 679 130 $
-1 709 595 $
-1 013 547 $
Rahoton kudi na baya-bayan nan game da kudin shiga na Elite Pharmaceuticals, Inc. shine ranar 31/03/2021. A cewar sabon rahoto game da sakamakon kudi na Elite Pharmaceuticals, Inc., yawan kudaden da Elite Pharmaceuticals, Inc. ya samu ya kai 4 395 531 US dollar kuma ya canza zuwa +227.1% idan aka kwatanta da shekara ta gaba. Sakamakon riba na Elite Pharmaceuticals, Inc. a cikin kwata na karshe shine -482 623 $, karuwar riba ta karu da +285.18% idan aka kwatanta da bara.
Kudin hannun jari Elite Pharmaceuticals, Inc.
Kudin hannun jari Elite Pharmaceuticals, Inc.
Sharorin Elite Pharmaceuticals, Inc. a yau, farashin kayayyaki ELTP yana da layi yanzu.
Rahoto kan sakamakon kudi na kamfanin Elite Pharmaceuticals, Inc., Elite Pharmaceuticals, Inc. shekara-shekara na samun kudin shiga ga shekara ta 2024.
